PharmaEssentia Corporation (TPE:6446)
937.00
-1.00 (-0.11%)
Jun 5, 2026, 1:30 PM CST
PharmaEssentia Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, PharmaEssentia stock has a consensus rating of "Buy" and an average price target of $778.83. The average 1-year stock price forecast is 16.88% lower than the current stock price, while the lowest is $550.00 (-41.30%) and the highest is $1,090 (+16.33%).
Price Target: $778.83 (-16.88%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PharmaEssentia stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 7 | 7 | 7 | 6 |
Financial Forecast
Revenue This Year
22.81B
from 15.63B
Increased by 45.92%
Revenue Next Year
36.84B
from 22.81B
Increased by 61.50%
EPS This Year
23.17
from 13.59
Increased by 70.49%
EPS Next Year
38.21
from 23.17
Increased by 64.89%
Financial currency is TWD.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 24.9B | ||
| Avg | 22.8B | ||
| Low | 21.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 59.1% | ||
| Avg | 45.9% | ||
| Low | 37.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 23.17 | ||
| Avg | 23.17 | ||
| Low | 23.17 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 70.5% | ||
| Avg | 70.5% | ||
| Low | 70.5% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.